BioMar Group A/S (CPH:BIOMAR)
Denmark · Delayed Price · Currency is DKK 108.00
+1.40 (1.31%)
At close: Jun 17, 2026
BioMar Group Income Statement
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 16,337 | 16,534 | 16,616 | 17,878 | 17,861 | 13,300 | |
Revenue Growth (YoY) | -8.53% | -0.49% | -7.06% | 0.10% | 34.29% | 14.18% |
Cost of Revenue | 12,669 | 12,921 | 13,218 | 14,773 | 16,830 | 12,415 |
Gross Profit | 3,668 | 3,613 | 3,398 | 3,105 | 1,031 | 885.7 |
Selling, General & Admin | 894 | 846 | 765 | 1,856 | 131.9 | - |
Other Operating Expenses | 1,268 | 1,268 | 1,157 | -0.58 | 18.56 | -3.74 |
Operating Expenses | 2,560 | 2,499 | 2,269 | 2,172 | 373.31 | 345.93 |
Operating Income | 1,108 | 1,114 | 1,129 | 932.99 | 657.8 | 539.78 |
Interest Expense | -196 | -193 | -290 | -259.73 | -139.81 | -42.65 |
Interest & Investment Income | 72 | 75 | 80 | 52.01 | 29.69 | 14.72 |
Earnings From Equity Investments | 53 | 55 | 36 | 6.26 | 129.81 | 45.31 |
Currency Exchange Gain (Loss) | -13 | -13 | -9 | -4.58 | -7.13 | 3.52 |
Other Non Operating Income (Expenses) | -35 | -35 | -1 | - | - | -21.23 |
EBT Excluding Unusual Items | 989.3 | 1,003 | 945 | 726.94 | 670.37 | 539.45 |
Merger & Restructuring Charges | -0.3 | -0.3 | - | - | - | - |
Impairment of Goodwill | - | - | - | -35.8 | -55.35 | - |
Gain (Loss) on Sale of Investments | 18 | 18 | - | 0.01 | 0 | 0.01 |
Asset Writedown | - | - | - | -36.95 | - | - |
Other Unusual Items | - | - | - | - | 94.29 | - |
Pretax Income | 1,007 | 1,021 | 945 | 654.2 | 709.3 | 539.46 |
Income Tax Expense | 264 | 266 | 239 | 170.67 | 153.76 | 141.7 |
Earnings From Continuing Operations | 743 | 755 | 706 | 483.53 | 555.54 | 397.76 |
Minority Interest in Earnings | -33 | -41 | -31 | -22.2 | -23.06 | -25.1 |
Net Income | 710 | 714 | 675 | 461.33 | 532.48 | 372.66 |
Net Income to Common | 710 | 714 | 675 | 461.33 | 532.48 | 372.66 |
Net Income Growth | 33.34% | 5.78% | 46.31% | -13.36% | 42.89% | -5.95% |
Shares Outstanding (Basic) | 0 | 0 | 0 | 0 | 0 | 0 |
Shares Outstanding (Diluted) | 0 | 0 | 0 | 0 | 0 | 0 |
Shares Change (YoY) | 0.17% | 0.00% | -0.04% | - | - | - |
EPS (Basic) | 7088.30 | 7143.00 | 6753.04 | 4613.32 | 5324.83 | 3726.60 |
EPS (Diluted) | 7088.30 | 7143.00 | 6753.04 | 4613.32 | 5324.83 | 3726.60 |
EPS Growth | 33.12% | 5.78% | 46.38% | -13.36% | 42.89% | -5.95% |
Free Cash Flow | 1,093 | 1,308 | 1,397 | 463.68 | 71.21 | 109.42 |
Free Cash Flow Per Share | 10912.00 | 13085.50 | 13976.29 | 4636.78 | 712.06 | 1094.22 |
Dividend Per Share | 8500.000 | 8500.000 | 7000.000 | 3500.000 | 3500.000 | 3500.000 |
Dividend Growth | 142.86% | 21.43% | 100.00% | - | - | - |
Gross Margin | 22.45% | 21.85% | 20.45% | 17.37% | 5.77% | 6.66% |
Operating Margin | 6.78% | 6.74% | 6.79% | 5.22% | 3.68% | 4.06% |
Profit Margin | 4.35% | 4.32% | 4.06% | 2.58% | 2.98% | 2.80% |
Free Cash Flow Margin | 6.69% | 7.91% | 8.41% | 2.59% | 0.40% | 0.82% |
EBITDA | 1,740 | 1,733 | 1,697 | 1,159 | 880.66 | 751.39 |
EBITDA Margin | 10.65% | 10.48% | 10.21% | 6.49% | 4.93% | 5.65% |
D&A For EBITDA | 632 | 619 | 568 | 226.35 | 222.85 | 211.61 |
EBIT | 1,108 | 1,114 | 1,129 | 932.99 | 657.8 | 539.78 |
EBIT Margin | 6.78% | 6.74% | 6.79% | 5.22% | 3.68% | 4.06% |
Effective Tax Rate | 26.22% | 26.05% | 25.29% | 26.09% | 21.68% | 26.27% |